UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 106

Sortiert nach

Phase III Study of Oral Compared With Intravenous Topotecan As Second-Line Therapy in Small-Cell Lung Cancer

Journal of clinical oncology, 2007-05, Vol.25 (15), p.2086-2092

2007

Volltextzugriff (PDF)

Treatment of Advanced Non–Small-Cell Lung Cancer in the Elderly: Results of an International Expert Panel

Journal of clinical oncology, 2005-05, Vol.23 (13), p.3125-3137

2005

Volltextzugriff (PDF)

Human Epidermal Growth Factor Receptor 2 Status and Interval Breast Cancer in a Population-Based Cancer Registry Study

Journal of clinical oncology, 2012-07, Vol.30 (19), p.2362-2368

2012

Volltextzugriff (PDF)

First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype

Expert review of anticancer therapy, 2009-04, Vol.9 (4), p.425-435

2009

Volltextzugriff (PDF)

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

The New England journal of medicine, 2016-11, Vol.375 (19), p.1823-1833

2016

Volltextzugriff (PDF)

Neurological Manifestations as a Harbinger of Myocarditis in Patients Treated With Immune Checkpoint Inhibitors

Journal of clinical oncology, 2023-02, Vol.41 (5), p.1151-1153

2023

Volltextzugriff (PDF)

Standard Versus Intensified Chemotherapy With Granulocyte Colony-Stimulating Factor Support in Small-Cell Lung Cancer: A Prospective European Organization for Research and Treatment of Cancer–Lung Cancer Group Phase III Trial—08923

Journal of clinical oncology, 2002-10, Vol.20 (19), p.3947-3955

2002

Volltextzugriff (PDF)

European Organization for Research and Treatment of Cancer (EORTC) 08957 Phase II Study of Topotecan in Combination with Cisplatin as Second-Line Treatment of Refractory and Sensitive Small Cell Lung Cancer

Clinical cancer research, 2003-01, Vol.9 (1), p.143-150

2003

Volltextzugriff (PDF)

Total metabolic tumor volume on 18F-fluorodeoxyglucose-positron emission tomography ([18F]-FDG-PET) scan: A potential prognostic factor in extensive-stage small cell lung cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.8574-8574

2022

Volltextzugriff (PDF)

Low PD-1 Expression in Cytotoxic CD8 + Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value

Clinical cancer research, 2018-01, Vol.24 (2), p.407-419

2018

Volltextzugriff (PDF)

Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial

Journal of clinical oncology, 2017-04, Vol.35 (12), p.1281-1287

2017

Volltextzugriff (PDF)

First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion–Positive NSCLC

The New England journal of medicine, 2023-11, Vol.389 (20), p.1839-1850

2023

Volltextzugriff (PDF)

Predictive and Prognostic Significance of Neuron-specific Enolase (NSE) in Non-small Cell Lung Cancer

Anticancer research, 2008-01, Vol.28 (1B), p.507-513

2008

Volltextzugriff (PDF)

HER-2 discordance between primary gastric carcinoma and paired lymph node metastasis

Human pathology, 2011-06, Vol.42 (6), p.909-910

2011

Volltextzugriff (PDF)

Multifactorial central nervous system recurrence susceptibility in patients with HER2‐positive breast cancer

Cancer, 2011-05, Vol.117 (9), p.1837-1846

2011

Volltextzugriff (PDF)

Adjuvant nab -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial

Journal of clinical oncology, 2023-04, Vol.41 (11), p.2007-2019

2023

Volltextzugriff (PDF)

Buccal Mucosa Cells as In vivo Model to Evaluate Gefitinib Activity in Patients with Advanced Non–Small Cell Lung Cancer

Clinical cancer research, 2007-11, Vol.13 (21), p.6518-6526

2007

Volltextzugriff (PDF)

The lung-immune prognostic index (LIPI) to predict early mortality among patients affected by advanced solid cancers under immune-checkpoint inhibitors treatments

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e14602-e14602

2023

Volltextzugriff (PDF)

Randomized Pilot Trial of Percutaneous Posterior Tibial Nerve Stimulation Versus Medical Therapy for the Treatment of Low Anterior Resection Syndrome: One-Year Follow-up

Diseases of the colon & rectum, 2020-12, Vol.63 (12), p.1602

2020

Volltextzugriff (PDF)

Herpes simplex virus type 1 dysregulates anti-fungal defenses preventing monocyte activation and downregulating toll-like receptor-2

Microbiology and immunology, 2008-12, Vol.52 (12), p.575-584

2008

Volltextzugriff (PDF)

Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial

Journal of clinical oncology, 2024-01, Vol.42 (2), p.180

2024

Volltextzugriff (PDF)

1 – 25 von 106

Suche als RSS-Feed

Aktive Filter

KollektionSingle Journals

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(98)

Sprache

Englisch
(106)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(54)
Science & Technology
(54)
Humans
(52)
Oncology
(39)
Female
(30)
Biological And Medical Sciences
(28)
Medical Sciences
(28)
Aged
(26)
Male
(25)
Middle Aged
(25)
Adult
(20)
Lung Neoplasms - Drug Therapy
(20)
Chemotherapy
(18)
Antineoplastic Agents
(15)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(15)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(15)
Pharmacology. Drug Treatments
(15)
Tumors
(14)
Lung Neoplasms - Pathology
(12)
Prognosis
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

Phase III Study of Oral Compared With Intravenous Topotecan As Second-Line Therapy in Small-Cell Lung Cancer

Treatment of Advanced Non–Small-Cell Lung Cancer in the Elderly: Results of an International Expert Panel

Pemetrexed Versus Pemetrexed and Carboplatin As Second-Line Chemotherapy in Advanced Non–Small-Cell Lung Cancer: Results of the GOIRC 02-2006 Randomized Phase II Study and Pooled Analysis With the NVALT7 Trial

Human Epidermal Growth Factor Receptor 2 Status and Interval Breast Cancer in a Population-Based Cancer Registry Study

First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype

LUX-Lung 8: A Global Phase III Trial of Afatinib (A) vs Erlotinib (E) as Second-Line Treatment in Patients (Pts) With Advanced Squamous Cell Carcinoma (SCC) of the Lung Following First-Line Platinum-Based Chemotherapy

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

Neurological Manifestations as a Harbinger of Myocarditis in Patients Treated With Immune Checkpoint Inhibitors

Standard Versus Intensified Chemotherapy With Granulocyte Colony-Stimulating Factor Support in Small-Cell Lung Cancer: A Prospective European Organization for Research and Treatment of Cancer–Lung Cancer Group Phase III Trial—08923

European Organization for Research and Treatment of Cancer (EORTC) 08957 Phase II Study of Topotecan in Combination with Cisplatin as Second-Line Treatment of Refractory and Sensitive Small Cell Lung Cancer

Total metabolic tumor volume on 18F-fluorodeoxyglucose-positron emission tomography ([18F]-FDG-PET) scan: A potential prognostic factor in extensive-stage small cell lung cancer

Low PD-1 Expression in Cytotoxic CD8 + Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value

Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial

First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion–Positive NSCLC

Predictive and Prognostic Significance of Neuron-specific Enolase (NSE) in Non-small Cell Lung Cancer

HER-2 discordance between primary gastric carcinoma and paired lymph node metastasis

Multifactorial central nervous system recurrence susceptibility in patients with HER2‐positive breast cancer

Adjuvant nab -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial

Buccal Mucosa Cells as In vivo Model to Evaluate Gefitinib Activity in Patients with Advanced Non–Small Cell Lung Cancer

The lung-immune prognostic index (LIPI) to predict early mortality among patients affected by advanced solid cancers under immune-checkpoint inhibitors treatments

Randomized Pilot Trial of Percutaneous Posterior Tibial Nerve Stimulation Versus Medical Therapy for the Treatment of Low Anterior Resection Syndrome: One-Year Follow-up

Herpes simplex virus type 1 dysregulates anti-fungal defenses preventing monocyte activation and downregulating toll-like receptor-2

Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial

Aktive Filter

Suchergebnisse filtern